Are we ready for pandemic influenza?
Identifieur interne : 006080 ( Main/Exploration ); précédent : 006079; suivant : 006081Are we ready for pandemic influenza?
Auteurs : Richard J. Webby [États-Unis] ; Robert G. WebsterSource :
- Science (New York, N.Y.) [ 1095-9203 ] ; 2003.
Descripteurs français
- KwdFr :
- Animaux, Antiviraux (ressources et distribution), Antiviraux (usage thérapeutique), Essais cliniques comme sujet, Flambées de maladies (), Grippe humaine (), Grippe humaine (transmission), Grippe humaine (virologie), Grippe humaine (épidémiologie), Humains, Maladies transmissibles émergentes (), Maladies transmissibles émergentes (transmission), Maladies transmissibles émergentes (virologie), Maladies transmissibles émergentes (épidémiologie), Organisation mondiale de la santé, Pratique en santé publique, Responsabilité légale, Réservoirs d'agents pathogènes, Surveillance de la population, Vaccins antigrippaux (effets indésirables), Vaccins antigrippaux (génétique), Vaccins antigrippaux (immunologie), Vaccins synthétiques (effets indésirables), Vaccins synthétiques (génétique), Vaccins synthétiques (immunologie), Virus de la grippe A (génétique), Virus de la grippe A (immunologie), Virus de la grippe A (pathogénicité), Virus de la grippe A (physiologie), Volaille (virologie).
- MESH :
- effets indésirables : Vaccins antigrippaux, Vaccins synthétiques.
- génétique : Vaccins antigrippaux, Vaccins synthétiques, Virus de la grippe A.
- immunologie : Vaccins antigrippaux, Vaccins synthétiques, Virus de la grippe A.
- pathogénicité : Virus de la grippe A.
- physiologie : Virus de la grippe A.
- ressources et distribution : Antiviraux.
- usage thérapeutique : Antiviraux, Grippe humaine, Maladies transmissibles émergentes.
- virologie : Grippe humaine, Maladies transmissibles émergentes, Volaille.
- épidémiologie : Grippe humaine, Maladies transmissibles émergentes.
- Animaux, Essais cliniques comme sujet, Flambées de maladies, Grippe humaine, Humains, Maladies transmissibles émergentes, Organisation mondiale de la santé, Pratique en santé publique, Responsabilité légale, Réservoirs d'agents pathogènes, Surveillance de la population.
English descriptors
- KwdEn :
- Animals, Antiviral Agents (supply & distribution), Antiviral Agents (therapeutic use), Clinical Trials as Topic, Communicable Diseases, Emerging (epidemiology), Communicable Diseases, Emerging (prevention & control), Communicable Diseases, Emerging (transmission), Communicable Diseases, Emerging (virology), Disease Outbreaks (prevention & control), Disease Reservoirs, Humans, Influenza A virus (genetics), Influenza A virus (immunology), Influenza A virus (pathogenicity), Influenza A virus (physiology), Influenza Vaccines (adverse effects), Influenza Vaccines (genetics), Influenza Vaccines (immunology), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (transmission), Influenza, Human (virology), Liability, Legal, Population Surveillance, Poultry (virology), Public Health Practice, Vaccines, Synthetic (adverse effects), Vaccines, Synthetic (genetics), Vaccines, Synthetic (immunology), World Health Organization.
- MESH :
- chemical , adverse effects : Influenza Vaccines, Vaccines, Synthetic.
- chemical , genetics : Influenza Vaccines, Vaccines, Synthetic.
- chemical , immunology : Influenza Vaccines, Vaccines, Synthetic.
- chemical , supply & distribution : Antiviral Agents.
- chemical , therapeutic use : Antiviral Agents.
- epidemiology : Communicable Diseases, Emerging, Influenza, Human.
- genetics : Influenza A virus.
- immunology : Influenza A virus.
- pathogenicity : Influenza A virus.
- physiology : Influenza A virus.
- prevention & control : Communicable Diseases, Emerging, Disease Outbreaks, Influenza, Human.
- transmission : Communicable Diseases, Emerging, Influenza, Human.
- virology : Communicable Diseases, Emerging, Influenza, Human, Poultry.
- Animals, Clinical Trials as Topic, Disease Reservoirs, Humans, Liability, Legal, Population Surveillance, Public Health Practice, World Health Organization.
Abstract
During the past year, the public has become keenly aware of the threat of emerging infectious diseases with the global spread of severe acute respiratory syndrome (SARS), the continuing threat of bioterrorism, the proliferation of West Nile virus, and the discovery of human cases of monkeypox in the United States. At the same time, an old foe has again raised its head, reminding us that our worst nightmare may not be a new one. In 2003, highly pathogenic strains of avian influenza virus, including the H5N1 and H7N7 subtypes, again crossed from birds to humans and caused fatal disease. Direct avian-to-human influenza transmission was unknown before 1997. Have we responded to these threats by better preparing for emerging disease agents, or are we continuing to act only as crises arise? Here we consider progress to date in preparedness for an influenza pandemic and review what remains to be done. We conclude by prioritizing the remaining needs and exploring the reasons for our current lack of preparedness for an influenza pandemic.
DOI: 10.1126/science.1090350
PubMed: 14645836
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003069
- to stream PubMed, to step Curation: 003069
- to stream PubMed, to step Checkpoint: 003319
- to stream Ncbi, to step Merge: 000466
- to stream Ncbi, to step Curation: 000466
- to stream Ncbi, to step Checkpoint: 000466
- to stream Main, to step Merge: 006582
- to stream Main, to step Curation: 006080
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Are we ready for pandemic influenza?</title>
<author><name sortKey="Webby, Richard J" sort="Webby, Richard J" uniqKey="Webby R" first="Richard J" last="Webby">Richard J. Webby</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Virology, Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Virology, Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Webster, Robert G" sort="Webster, Robert G" uniqKey="Webster R" first="Robert G" last="Webster">Robert G. Webster</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:14645836</idno>
<idno type="pmid">14645836</idno>
<idno type="doi">10.1126/science.1090350</idno>
<idno type="wicri:Area/PubMed/Corpus">003069</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003069</idno>
<idno type="wicri:Area/PubMed/Curation">003069</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003069</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003319</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003319</idno>
<idno type="wicri:Area/Ncbi/Merge">000466</idno>
<idno type="wicri:Area/Ncbi/Curation">000466</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000466</idno>
<idno type="wicri:Area/Main/Merge">006582</idno>
<idno type="wicri:Area/Main/Curation">006080</idno>
<idno type="wicri:Area/Main/Exploration">006080</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Are we ready for pandemic influenza?</title>
<author><name sortKey="Webby, Richard J" sort="Webby, Richard J" uniqKey="Webby R" first="Richard J" last="Webby">Richard J. Webby</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Virology, Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Virology, Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Webster, Robert G" sort="Webster, Robert G" uniqKey="Webster R" first="Robert G" last="Webster">Robert G. Webster</name>
</author>
</analytic>
<series><title level="j">Science (New York, N.Y.)</title>
<idno type="eISSN">1095-9203</idno>
<imprint><date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antiviral Agents (supply & distribution)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Clinical Trials as Topic</term>
<term>Communicable Diseases, Emerging (epidemiology)</term>
<term>Communicable Diseases, Emerging (prevention & control)</term>
<term>Communicable Diseases, Emerging (transmission)</term>
<term>Communicable Diseases, Emerging (virology)</term>
<term>Disease Outbreaks (prevention & control)</term>
<term>Disease Reservoirs</term>
<term>Humans</term>
<term>Influenza A virus (genetics)</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza A virus (pathogenicity)</term>
<term>Influenza A virus (physiology)</term>
<term>Influenza Vaccines (adverse effects)</term>
<term>Influenza Vaccines (genetics)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (transmission)</term>
<term>Influenza, Human (virology)</term>
<term>Liability, Legal</term>
<term>Population Surveillance</term>
<term>Poultry (virology)</term>
<term>Public Health Practice</term>
<term>Vaccines, Synthetic (adverse effects)</term>
<term>Vaccines, Synthetic (genetics)</term>
<term>Vaccines, Synthetic (immunology)</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Antiviraux (ressources et distribution)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Essais cliniques comme sujet</term>
<term>Flambées de maladies ()</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (transmission)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Maladies transmissibles émergentes ()</term>
<term>Maladies transmissibles émergentes (transmission)</term>
<term>Maladies transmissibles émergentes (virologie)</term>
<term>Maladies transmissibles émergentes (épidémiologie)</term>
<term>Organisation mondiale de la santé</term>
<term>Pratique en santé publique</term>
<term>Responsabilité légale</term>
<term>Réservoirs d'agents pathogènes</term>
<term>Surveillance de la population</term>
<term>Vaccins antigrippaux (effets indésirables)</term>
<term>Vaccins antigrippaux (génétique)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Vaccins synthétiques (effets indésirables)</term>
<term>Vaccins synthétiques (génétique)</term>
<term>Vaccins synthétiques (immunologie)</term>
<term>Virus de la grippe A (génétique)</term>
<term>Virus de la grippe A (immunologie)</term>
<term>Virus de la grippe A (pathogénicité)</term>
<term>Virus de la grippe A (physiologie)</term>
<term>Volaille (virologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Influenza Vaccines</term>
<term>Vaccines, Synthetic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Influenza Vaccines</term>
<term>Vaccines, Synthetic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term>
<term>Vaccines, Synthetic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Vaccins antigrippaux</term>
<term>Vaccins synthétiques</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Vaccins antigrippaux</term>
<term>Vaccins synthétiques</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
<term>Vaccins synthétiques</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Disease Outbreaks</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="ressources et distribution" xml:lang="fr"><term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
<term>Grippe humaine</term>
<term>Maladies transmissibles émergentes</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Maladies transmissibles émergentes</term>
<term>Volaille</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Influenza, Human</term>
<term>Poultry</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Maladies transmissibles émergentes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Clinical Trials as Topic</term>
<term>Disease Reservoirs</term>
<term>Humans</term>
<term>Liability, Legal</term>
<term>Population Surveillance</term>
<term>Public Health Practice</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Essais cliniques comme sujet</term>
<term>Flambées de maladies</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Maladies transmissibles émergentes</term>
<term>Organisation mondiale de la santé</term>
<term>Pratique en santé publique</term>
<term>Responsabilité légale</term>
<term>Réservoirs d'agents pathogènes</term>
<term>Surveillance de la population</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">During the past year, the public has become keenly aware of the threat of emerging infectious diseases with the global spread of severe acute respiratory syndrome (SARS), the continuing threat of bioterrorism, the proliferation of West Nile virus, and the discovery of human cases of monkeypox in the United States. At the same time, an old foe has again raised its head, reminding us that our worst nightmare may not be a new one. In 2003, highly pathogenic strains of avian influenza virus, including the H5N1 and H7N7 subtypes, again crossed from birds to humans and caused fatal disease. Direct avian-to-human influenza transmission was unknown before 1997. Have we responded to these threats by better preparing for emerging disease agents, or are we continuing to act only as crises arise? Here we consider progress to date in preparedness for an influenza pandemic and review what remains to be done. We conclude by prioritizing the remaining needs and exploring the reasons for our current lack of preparedness for an influenza pandemic.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Tennessee</li>
</region>
</list>
<tree><noCountry><name sortKey="Webster, Robert G" sort="Webster, Robert G" uniqKey="Webster R" first="Robert G" last="Webster">Robert G. Webster</name>
</noCountry>
<country name="États-Unis"><region name="Tennessee"><name sortKey="Webby, Richard J" sort="Webby, Richard J" uniqKey="Webby R" first="Richard J" last="Webby">Richard J. Webby</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006080 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006080 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:14645836 |texte= Are we ready for pandemic influenza? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:14645836" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |